CD40 anticorps (AA 201-277) (FITC)

N° du produit ABIN681845

L’anticorps Lapin Polyclonal anti-CD40 a été validé pour FACS, WB, IF (p) et IF (cc). Il convient pour détecter CD40 dans des échantillons de Humain, Souris et Lapin.

Aperçu rapide pour CD40 anticorps (AA 201-277) (FITC) (ABIN681845)

Antigène: CD40

Reactivité: Humain, Souris, Lapin

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp CD40 est conjugé à/à la FITC

Application: Flow Cytometry (FACS), Western Blotting (WB), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunofluorescence (Cultured Cells) (IF (cc))

Détail du produit anti-CD40 anticorps (FITC)

Épitope: AA 201-277

Réactivité croisée: Humain, Souris, Lapin

Homologie: Rat,Dog,Cow,Pig,Chicken

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human TNFRSF5

Isotype: IgG

Information d'application

Indications d'application: FCM 1:20-100
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Date de péremption: 12 months

Détails sur CD40

Antigène: CD40

Autre désignation: TNFRSF5

Sujet:

Synonyms: p50, Bp50, CDW40, TNFRSF5, Tumor necrosis factor receptor superfamily member 5, B-cell surface antigen CD40, CD40L receptor, CD40

Background: Receptor for TNFSF5/CD40LG. Transduces TRAF6- and MAP3K8-mediated signals that activate ERK in macrophages and B cells, leading to induction of immunoglobulin secretion.

ID gène: 958

UniProt: P25942

Pathways: Signalisation NF-kappaB, Cellular Response to Molecule of Bacterial Origin, M Phase, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints